SISB INVESTMENT ADVISERS (UK) LTD
Institutional investor · Portfolio as of Q1 2026
SEC EDGAR SourceSEC Filings
SB INVESTMENT ADVISERS (UK) LTD manages $7.7B across 10 positions as of Q1 2026. Top holdings: CPNG (70.7%), GRAB (19.0%), RLAY (3.6%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.
Q1 2026 Summary
Trimmed 4. No standout high-conviction moves this quarter. Portfolio: $7.7B across 10 positions.
Top holdings by portfolio weight
CPNG70.74%
GRAB19.03%
RLAY3.59%
COMP2.08%
VIR1.27%
AUR1.06%
ROIV0.96%
NRGV0.66%
YMM0.57%
DNA0.05%
Position Outcomes
Best and worst performing positions by estimated return
Top Losers
Upgrade to Pro to see the worst-performing positions.
View plansCost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Top Holdings10 positions
Activity:
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
COUPANG INC | 289.5M | $5.5B | 70.7% | $48.75 | -66.93% | 21 qtrssince 2021-Q1 | Unchanged 0 |
GRAB HOLDINGS LIMITED | 401.8M | $1.5B | 19.0% | $7.08 | -49.89% | 18 qtrssince 2021-Q4 | Unchanged 0 |
RELAY THERAPEUTICS INC | 27.9M | $277.7M | 3.6% | $39.98 | -69.48% | 23 qtrssince 2020-Q3 | Unchanged 0 |
COMPASS INC | 22M | $160.9M | 2.1% | $13.50 | -41.63% | 20 qtrssince 2021-Q2 | Decreased 0 |
VIR BIOTECHNOLOGY INC | 10.9M | $98.1M | 1.3% | $12.12 | -27.48% | 26 qtrssince 2019-Q4 | Decreased 0 |
AURORA INNOVATION INC | 19.8M | $81.6M | 1.1% | $11.41 | -32.43% | 18 qtrssince 2021-Q4 | Unchanged 0 |
ROIVANT SCIENCES LTD | 2.7M | $74M | 1.0% | $10.64 | +175.28% | 18 qtrssince 2021-Q4 | Decreased 0 |
ENERGY VAULT HOLDINGS INC | 15.5M | $51.3M | 0.7% | $9.89 | -40.04% | 16 qtrssince 2022-Q2 | Decreased 0 |
FULL TRUCK ALLIANCE CO LTD | 5.3M | $43.8M | 0.6% | $12.11 | -28.50% | 15 qtrssince 2022-Q3 | Unchanged 0 |
GINKGO BIOWORKS HOLDINGS INC | 610,729 | $3.7M | 0.0% | $67.60 | -88.59% | 14 qtrssince 2022-Q4 | Unchanged 0 |
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer